Your browser doesn't support javascript.
loading
Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video).
Jukema, Jelmer B; Kusters, Carolus H J; Jong, Martijn R; Fockens, Kiki N; Boers, Tim; van der Putten, Joost A; Pouw, Roos E; Duits, Lucas C; Weusten, Bas L A M; Herrero, Lorenza Alvarez; Houben, Martin H M G; Nagengast, Wouter B; Westerhof, Jessie; Alkhalaf, Alaa; Mallant-Hent, Rosalie; Scholten, Pieter; Ragunath, Krish; Seewald, Stefan; Elbe, Peter; Silva, Francisco Baldaque; Barret, Maximilien; Ortiz Fernández-Sordo, Jacobo; Moral Villarejo, Guiomar; Pech, Oliver; Beyna, Torsten; Montazeri, Nahid S M; der Sommen, Fons van; de With, Peter H; de Groof, A Jeroen; Bergman, Jacques J.
Affiliation
  • Jukema JB; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Kusters CHJ; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • Jong MR; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Fockens KN; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Boers T; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • van der Putten JA; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • Pouw RE; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Duits LC; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Weusten BLAM; Department of Gastroenterology and Hepatology, UMC Utrecht, University of Utrecht, Utrecht, the Netherlands; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Herrero LA; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Houben MHMG; Department of Gastroenterology and Hepatology, HagaZiekenhuis Den Haag, Den Haag, the Netherlands.
  • Nagengast WB; Department of Gastroenterology and Hepatology, UMC Groningen, University of Groningen, Groningen, the Netherlands.
  • Westerhof J; Department of Gastroenterology and Hepatology, UMC Groningen, University of Groningen, Groningen, the Netherlands.
  • Alkhalaf A; Department of Gastroenterology and Hepatology, Isala Hospital Zwolle, Zwolle, the Netherlands.
  • Mallant-Hent R; Department of Gastroenterology and Hepatology, Flevoziekenhuis Almere, Almere, the Netherlands.
  • Scholten P; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • Ragunath K; Department of Gastroenterology and Hepatology, Royal Perth Hospital, Curtin University, Perth, WA, Australia.
  • Seewald S; Department of Gastroenterology and Hepatology, Hirslanden Klinik, Zurich, Switzerland.
  • Elbe P; Department of Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden; Division of Surgery, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
  • Silva FB; Department of Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden; Center for Advanced Endoscopy Carlos Moreira da Silva, Gastroenterology Department, Pedro Hispano Hospital, ULSM Matosinhos, Portugal.
  • Barret M; Department of Gastroenterology and Hepatology, Cochin Hospital Paris, Paris, France.
  • Ortiz Fernández-Sordo J; Department of Gastroenterology and Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Moral Villarejo G; Department of Gastroenterology and Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Pech O; Department of Gastroenterology and Hepatology, St. John of God Hospital, Regensburg, Germany.
  • Beyna T; Department of Gastroenterology and Hepatology, Evangalisches Krankenhaus Düsseldorf, Düsseldorf, Germany.
  • Montazeri NSM; Biostatistics Unit, Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • der Sommen FV; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • de With PH; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • de Groof AJ; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bergman JJ; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: j.j.bergman@amsterdamumc.nl.
Gastrointest Endosc ; 2024 Apr 16.
Article in En | MEDLINE | ID: mdl-38636819
ABSTRACT
BACKGROUND AND

AIMS:

Characterization of visible abnormalities in patients with Barrett's esophagus (BE) can be challenging, especially for inexperienced endoscopists. This results in suboptimal diagnostic accuracy and poor interobserver agreement. Computer-aided diagnosis (CADx) systems may assist endoscopists. We aimed to develop, validate, and benchmark a CADx system for BE neoplasia.

METHODS:

The CADx system received pretraining with ImageNet and then consecutive domain-specific pretraining with GastroNet, which includes 5 million endoscopic images. It was subsequently trained and internally validated using 1758 narrow-band imaging (NBI) images of early BE neoplasia (352 patients) and 1838 NBI images of nondysplastic BE (173 patients) from 8 international centers. CADx was tested prospectively on corresponding image and video test sets with 30 cases (20 patients) of BE neoplasia and 60 cases (31 patients) of nondysplastic BE. The test set was benchmarked by 44 general endoscopists in 2 phases (phase 1, no CADx assistance; phase 2, with CADx assistance). Ten international BE experts provided additional benchmark performance.

RESULTS:

Stand-alone sensitivity and specificity of the CADx system were 100% and 98% for images and 93% and 96% for videos, respectively. CADx outperformed general endoscopists without CADx assistance in terms of sensitivity (P = .04). Sensitivity and specificity of general endoscopists increased from 84% to 96% and 90% to 98% with CAD assistance (P < .001). CADx assistance increased endoscopists' confidence in characterization (P < .001). CADx performance was similar to that of the BE experts.

CONCLUSIONS:

CADx assistance significantly increased characterization performance of BE neoplasia by general endoscopists to the level of expert endoscopists. The use of this CADx system may thereby improve daily Barrett surveillance.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gastrointest Endosc Year: 2024 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gastrointest Endosc Year: 2024 Type: Article Affiliation country: Netherlands